(16426550), R. M. S., (14959088), T. E. Z., (15015803), Z. B., (16426553), V. S., (15062851), W. X., (16426556), R. F., . . . (15043076), D. A. B. (2025). Figure S1 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma.
芝加哥风格引文(16426550), Renee Maria Saliby, et al. Figure S1 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab Plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma. 2025.
MLA引文(16426550), Renee Maria Saliby, et al. Figure S1 from Circulating and Intratumoral Immune Determinants of Response to Atezolizumab Plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma. 2025.